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Abstract:  Objective: To determine the platelet recovery and yield of the 
PRGF-U1 protocol in a Peruvian population. Methods: An observational, 
descriptive and cross-sectional study was conducted with a simple random 
probability sample of 32 patients who attended the Laboratorio Scalab in 
Trujillo, Peru. A blood sample was taken from each patient in order to obtain 
the concentration of platelets and before and after the PRGF-U1 protocol, 
in order to determine platelet recovery and yield. To compare basal platelet 
concentrations and platelet recovery and yield with gender and age, the chi-
square test, Student's t-distribution and Pearson's correlation coefficient were 
used considering a significance level of p<0.05. Results: Platelet yield was less 
than 2.2 in two patients and greater than or equal to 2.2 in 30 patients; platelet 
recovery was equal to 0.4 in 30 patients and greater than 0.4 in two patients. A 
statistically significant relationship (p<0.05) between basal platelet count and age 
was found when comparing basal platelet count, platelet recovery and platelet 
yield according to gender and age, but no significant relationship between the 
other variables (p>0.05). Conclusion: The PRGF-U1 protocol presents optimal 
platelet yield and minimal expected platelet recovery.
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INTRODUCTION.
The field of medicine and dentistry is rapidly advancing toward the 
development of non-invasive procedures and accelerated treatments 
that can result in a good functional recovery of patients, in order to 
improve their quality of life. In recent years, the concept of stimulation 
and maximization of healing mechanisms has gained prominence and 
generated simple and cost-effective procedures that have had a potential 
impact by reducing the cost of treatments.1-3
One of these simple and cost-effective procedures, which minimizes 
the consequences of invasive surgical treatments, is platelet rich plasma 
(PRP) or plasma rich in growth factors (PRGF), which is a rich source of 
growth factors (GFs). PRP is an autologous biological gel derived from 
the patient's blood that contains a higher platelet concentration than 
circulating blood. PRP is an easily accessible source of GFs secreted by 
platelets when the healing process begins, allowing for the acceleration 
and improvement of the healing processes and tissue regeneration.1-4
Techniques for obtaining PRP vary regarding the centrifugation, 
number of steps and the speed of centrifugation, and the use of calcium 
chloride or other substances for its activation.1,36  One of the most widely 
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used protocols and considered the gold standard for 
obtaining PRP was proposed by Anitua and Andia, and 
has shown good clinical results in improving the healing 
of hard and soft tissues.1,7 This protocol obtains PRP by 
means of a single centrifugation at 1800 revolutions per 
minute (rpm) during 8 minutes producing 280g (relative 
centrifugal force, RCF).1,2,8 
Currently there is a problem with commercial kits 
because they require the use of already costly calibrated 
centrifuges without the possibility of using other 
centrifuges. Therefore, a new protocol was proposed 
(plasma rich in universal growth factors 1 or PRGF-U11) 
in a Latin American population (Peru) to allow obtaining 
PRP using a conventional centrifuge, thus providing 
wider access to the use of GF and to its advantages in 
dental surgery. Consequently, the aim of this study 
was to determine the platelet recovery and yield of the 
PRGF-U1 protocol in a Peruvian population.
 
MATERIALS AND METHODS.
This is an observational, descriptive and cross-sectional 
study conducted at the Universidad Nacional de Trujillo 
(UNT) and at Laboratorio Scalab in Trujillo, Peru. It was 
approved by the bioethics committee of the postgraduate 
school of medical sciences of the UNT. The sample 
consisted of 32 blood samples from 32 patients who 
attended the Laboratorio Scalab. Selection of patients was 
done by simple randomized sampling.
Selection criteria
Blood samples were included from patients over 
18 years of age, who had a normal basal platelet count 
(150000-400000 platelets/μL) that required some type of 
hematological analysis and without distinction of gender. 
Subjects who reported consumption of medication that 
could cause a variation in blood parameters, those who 
had blood parameters outside the normal range, and those 
who did not sign the informed consent were excluded 
from the study.
Blood sample
A peripheral blood sample was collected from each 
fasting patient by a trained laboratory technician using 
the vacutainer system. All of the samples were taken into 
3.2% sodium citrate test tubes, each with a capacity of 
approximately 4.5ml. Patients signed an informed consent 
form prior to obtaining the blood sample.
Protocol
A 0.5ml sample was extracted to corroborate if the 
basal platelet count was within the normal range to meet 
the inclusion and exclusion criteria. The rest of the sample 
was processed following the PRGF-U11 protocol
using a centrifugation of 1600 revolutions per minute 
(rpm) on a rotor with a radius of 97.6mm, for 8 minutes 
(280g), and then extracting the PRP and platelet-poor 
plasma (PPP).
For the platelet count, an automatic XS-1000i Roche 
cell counter was used and estimating counts per high 
power field on a Wright's-stained blood smear.
Platelet recovery and yield
Platelet yield was obtained by dividing the platelet 
count in the PRP by the basal platelet count to determine 
how many times more platelets the PRP had in relation 
to basal platelets and then classify it as normal (<2.2) or 
optimal (≥2.2). Platelet recovery was obtained by dividing 
the platelet count in the PPP by the basal platelet count to 
determine how many times more platelets the PPP had in 
relation to the amount of basal platelets and then classify 
it as low (<0.4), minimal (0.4), or optimal (>0.4).
Statistical analysis
The statistical package SPSS 23.0 (IBM, USA) was 
used to process the data. Pearson's statistical correlation 
test was used to compare baseline platelet counts with 
age. Student's t-test was used to compare basal platelet 
count with gender, platelet yield and recovery with age. 
The chi-square test was used to compare platelet yield and 
recovery with gender, all these statistical tests considered 
a significance level of p<0.05.
RESULTS.
Platelet yield was less than 2.2 in 2 patients and greater 
than or equal to 2.2 in 30 patients; platelet recovery 
was equal to 0.4 in 30 patients and greater than 0.4 in 2 
patients. 
Comparing basal platelet count, platelet yield and 
recovery with gender and age, it was found that there is 
a statistically significant relationship (p<0.05) between 
basal platelet count and age, and there is no significant 
relationship between the other variables (p>0.05) (Table 
1 and Table 2).
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DISCUSSION.
The results of the present study show that the platelet 
yield and recovery of PRGF-U1, when the centrifuge is 
previously calibrated to obtain 280g forces, is optimal. 
In addition, it shows that the highest concentrations of 
basal platelets are found in people less than 40 years of age 
and that they are lower as age progresses. These results are 
similar to those found by Biino et al.,9 Troussard et al.,10 
and Jones,11 who state that platelet count decreases with 
age because as age progresses the haematopoietic stem cell 
reserve decreases.  
It also shows that the concentration of basal platelets 
does not vary with gender. These results are different 
from those found by Biino et al.,9 who reported that 
differences exist and that women have a higher number 
of basal platelets than men. In addition, the results 
obtained here show that there is no difference between 
PRP performance and recovery with age and gender. 
No study has reported similar results using the same 
methodology and comparing these two variables.
It should be noted that this study has two limitations: 
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Variable  n Mean Standard Deviation  p-value
Gender Male 15 276000 88309 0.131*
 Female 17 234412 62520 
Age <40 years 16 287750 83073 0.005**  (r 2 = - 0.89)
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Platelet yield Gender Male 15 2 13 0.212*
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Platelet recovery Gender Male 15 13 2 0.212*
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Table 1. Basal platelet count, per microliter, according to gender and age.
Table 2. Platelet yield and recovery according to gender and age.
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the selection of the patients’ health condition and the 
size of the sample. It was assumed the patient's health 
condition was normal when the platelet count was within 
the normal parameters. 
This means that the subjects who participated in the 
present study may not necessarily have been healthy, 
since for example, diabetes like other systemic diseases, 
does not affect platelet counts.
However, despite this limitation, which may influence 
results and introduce bias, it is observed this way of 
obtaining PRP could lead to clinical improvements 
taking into consideration that the basal platelet count is 
within normal parameters. 
In addition, it is helpful that any centrifuge may be 
used for the PRGF-U1 protocol using the following 
mathematical formula to calculate rpm, without the need 
for a commercial kit: RCF=1.12 x Radius x (rpm/1000).2
 CONCLUSION.
The PRGF-U1 protocol presents optimal platelet yield 
and minimal expected platelet recovery.
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